Medtronic

Address:
710 Medtronic Parkway
Minneapolis
MN 55432
United States of America

Medtronic articles

Displaying 1 - 20 of 26

Pilot study of investigational extravascular ICD system

Pilot study of investigational extravascular ICD system
Medtronic has announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and antitachycardia pacing therapy all in one system, with a device size similar to transvenous ICDs. The first patient implant was performed at Christchurch Hospital in New Zealand, representing the first intended long-term patient use of the Medtronic EV ICD system.
13th August 2018

Implantable system for Remodulin receives FDA approval

Implantable system for Remodulin receives FDA approval
Medtronic has received FDA approval for the Implantable System for Remodulin (ISR) to treat patients with pulmonary arterial hypertension (PAH). Through a first-of-its-kind collaboration, the Medtronic SynchroMed II drug delivery system and cardiac catheter technologies were leveraged to deliver the PAH medication Remodulin (treprostinil) Injection developed by United Therapeutics. United Therapeutics will lead the commercial promotion of the ISR, with Medtronic support.
2nd August 2018

Heart pump implant procedure receives FDA approval

Heart pump implant procedure receives FDA approval
Medtronic has received FDA approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for patients with advanced heart failure. The HVAD System is the smallest commercially available LVAD, and the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest.
16th July 2018


MiniMed 670G hybrid closed loop system receives CE Mark

MiniMed 670G hybrid closed loop system receives CE Mark
Medtronic has announced it has received CE (Conformité Européenne) Mark for the MiniMed 670G hybrid closed loop system - the first and only system to automate and personalise the delivery of basal insulin 24 hours a day. The system is CE Mark approved for the treatment of people with type 1 diabetes 7 years of age and older with ongoing studies to expand the indication to additional patient populations.
29th June 2018

DBS Clinician Programmer addresses day-to-day management challenges

DBS Clinician Programmer addresses day-to-day management challenges
Medtronic has announced that the FDA recently approved its Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application, which followed closely on the recent achievement of CE Mark this past March. The ActivaProgramming Application has been designed with the input of over a hundred clinicians from around the world and is managed on the Samsung Galaxy Tab S2 tablet interface.
18th June 2018

MRI-guided laser ablation system receives CE Mark approval

MRI-guided laser ablation system receives CE Mark approval
Medtronic plc has announced the CE (Conformité Européenne) Mark and European launch of the Visualase MRI-Guided Laser Ablation System. The Visualase system provides advanced MRI-guided laser ablation technology and can be used in neurosurgery procedures. With the Visualase system, laser energy is delivered to the target area using an applicator. As light is delivered through the applicator, temperatures in the target area begin to rise, destroying the unwanted soft tissue.
13th April 2018

Continuous glucose monitoring system receives FDA approval

Continuous glucose monitoring system receives FDA approval
Medtronic has announced it received FDA approval for its Guardian Connect continuous glucose monitoring (CGM) system, for people with diabetes ages 14 to 75 years. The Guardian Connect system is the first smart standalone CGM system to help people with diabetes stay ahead of high and low glucose events. The Guardian Connect system empowers people using multiple daily injections (MDI) to more proactively manage their diabetes.
13th March 2018

Advance Infusion Set: a simple change for the better

Advance Infusion Set: a simple change for the better
  Medtronic has announced the Minimed Mio Advance Infusion Set, designed with a pre-loaded inserter for quicker and easier set changes that require fewer steps. It works with major pump brands with luer-lock or Minimed connectors including Medtronic, Roche and Animas.
2nd March 2018

Intravenous delivery system for treprostinil

Intravenous delivery system for treprostinil
Current guidelines in the United States and Europe recommend treatment with parenteral prostanoids for severe or rapidly progressing pulmonary arterial hypertension (PAH).2-4 However, risks and complexities associated with the current intravenous (IV) and subcutaneous (SC) delivery systems limit the acceptance of parenteral therapy. IV delivery via an indwelling central venous catheter is associated with the risk of serious bloodstream infections (BSI) and unintended catheter dislodgment, which may be fatal.
1st February 2018

World's smallest fully implantable SCS receives CE Mark

World's smallest fully implantable SCS receives CE Mark
Medtronic has announced that it received CE Mark for the Intellis platform for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) as an aid in the management of certain types of chronic pain. Intellis, the world's smallest fully implantable SCS neurostimulator, simplifies and improves the patient experience with improved battery performance that can power the EvolveSM workflow, which standardises guidance and balances high-dose (HD) and low-dose (LD) SCS therapy settings.
8th November 2017

HeartWare approved for destination therapy

HeartWare approved for destination therapy
  Medtronic plc has received FDA approval for its HeartWare HVAD System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. The HVAD System, a left ventricular assist device or LVAD, helps the heart pump and increases the amount of blood that flows through the body.
2nd October 2017

Detachable coil system aids peripheral vasculature

Detachable coil system aids peripheral vasculature
At the ongoing Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Copenhagen, Denmark, Medtronic has unveiled its new Concerto 3D Detachable Coil System. The device, which is now available to physicians in the U.S. and Europe, is intended to be used for embolisations in the peripheral arteries and veins. The device folds into a dense and knotty shape which helps to fill in an aneurysm, for example, similar to how neurovascular aneurysms are now commonly treated.
20th September 2017

Next-gen spinal cord stimulator receives FDA Approval

Next-gen spinal cord stimulator receives FDA Approval
Medtronic has announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardises guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
19th September 2017

StealthStation supports ear, nose, and throat procedures

StealthStation supports ear, nose, and throat procedures
Medtronic plc has announced the global launch of the StealthStation ENT, a new surgical navigation system designed for surgeons treating conditions within the ear, nose, and throat (ENT) anatomy. The company has received U.S. Food and Drug Administration 510k clearance and CE Mark for the system. StealthStation ENT uses a proprietary electromagnetic (EM) tracking technology.
15th September 2017

Attain Stability Quad MRI SureScan receives CE Mark

Attain Stability Quad MRI SureScan receives CE Mark
Medtronic has announced it has received CE Mark for the Attain Stability Quad MRI SureScan left heart lead. Paired with Medtronic quadripolar cardiac resynchronisation therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead features novel, active-fixation technology that is designed for precise lead placement and stability. In the United States, the Attain Stability Quad lead is under evaluation in a clinical trial and is not approved for sale.
24th August 2017

Pericardial aortic surgical valve approved in U.S. and Europe

Pericardial aortic surgical valve approved in U.S. and Europe
Medtronic plc has announced CE mark and U.S. FDA approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease. The Avalus valve leverages proven surgical bioprosthetic valve concepts with added features designed to enhance clinical performance, helping to address the contemporary needs of cardiac surgeons, as well as patients who are candidates for aortic valve replacement.
3rd August 2017

CoreValve Evolut PRO receives CE Mark and European launch

CoreValve Evolut PRO receives CE Mark and European launch
Medtronic plc has announced CE mark and European launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at intermediate, high or extreme risk for open heart surgery. Clinical data for the Evolut PRO valve was recently unveiled at the American College of Cardiology (ACC) 66th Annual Scientific Session, and showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and excellent hemodynamics.
1st August 2017

Aortic valves approved for intermediate risk patients

Aortic valves approved for intermediate risk patients
  Medtronic has announced the expanded U.S. FDA approval of the self-expanding CoreValve Evolut transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery.
12th July 2017

Micra pacemaker survives flight to space

Micra pacemaker survives flight to space
The Medtronic Micra is the smallest pacemaker currently available. It’s so small that it’s delivered via a catheter and attached to the endocardium of the heart, where its internal battery paces the heart for years. It’s certainly an incredible piece of technology, but a high school student had a wild idea of testing whether such a fine piece of electronics can withstand a flight into space.
7th July 2017

Micra pacemaker goes on a space flight

Micra pacemaker goes on a space flight
These days astronauts are some of the healthiest and physically robust individuals that NASA can get a hold of. But one day we may see all kinds of people going to space, even those with heart conditions. Shelbi Klingsporn, a Nebraska high school student had the idea to test whether an existing pacemaker is able to handle the vibrations, radiation, and weightlessness of space to get a sense of whether pacemakers have a future in the final frontier.
19th June 2017


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Connected World Summit 2019
22nd October 2019
United Kingdom The Business Design Centre, London
Hotspots Specials 2019
24th October 2019
Germany Böblingen, Germany
IoT Solutions World Congress 2019
29th October 2019
Spain Barcelona
Maintec 2019
30th October 2019
United Kingdom NEC, Birmingham
NOAH Conference 2019
30th October 2019
United Kingdom Old Billingsgate, London